Latest Sanofi News & Updates

See the latest news and media coverage for Sanofi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sanofi

R&D-driven, AI-powered biopharmaceutical company

sanofi.com

Headquarters: Paris, France
Company type: Public company
Number of employees: 90,000+

Last updated Today

Latest news about Sanofi

In short: Sanofi appointed Belén Garijo as CEO, expanded its AI hub in Toronto, and advanced its pipeline despite the discontinuation of several late-stage trials.

Company announcements

June 12 Sanofi

Sanofi announces FDA accelerated approval for Tzield

The authorization covers children aged eight to 17 recently diagnosed with stage 3 type 1 diabetes and is supported by PROTECT phase 3 data and over 900 treated patients.

June 10 Sanofi

Sanofi stops MOBILIZE phase 3 study of riliprubart in CIDP

The study was halted after an interim analysis showed insufficient efficacy; no safety concerns were noted.

June 8 Sanofi

Sanofi's Sarclisa subcutaneous approved in EU

It is the first anticancer treatment to be administered via an on-body injector, offering flexibility for home or outpatient settings.

May 28 Sanofi

Sanofi's venglustat granted FDA priority review for GD3

If approved, it would be the first treatment for neurological manifestations of type 3 Gaucher disease.

Media coverage

June 16 Law360

Sanofi Sued Over Qunol CoQ10 'Superior Absorption' Claims - Law360

Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows...

June 15 Seeking Alpha

Oppenheimer’s top buy ideas and sell ideas within each sector

Oppenheimer analysts remain bullish, citing beta and momentum, and offer buy/sell recommendations for each sector.

June 12 Reuters

FDA approves Sanofi's drug for stage 3 type 1 diabetes in children

The U.S. Food and ‌Drug Administration approved Sanofi's injection to slow ⁠the loss of the body's own insulin production in children aged 8 ‌to ⁠17...

June 10 Yahoo Finance

Sanofi Ends Late-Stage Study on Neurology Drug Over Weak Results

Sanofi SNY announced that it is discontinuing the phase III MOBILIZE study, which is evaluating its...

Never miss news about Sanofi

Track Sanofi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sanofi competitors & trending companies

Browse news for competitors to Sanofi and other trending companies.